Instead of continuing to rely on trial-and-error testing, pharmaceutical scientists are increasingly turning to computer software to create better treatments.
The Petri Dish: Silicon Therapeutics acquired for $450M, Resilience buys Boston site bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Roivant Sciences today announced it has entered into a definitive agreement to acquire Silicon Therapeutics for $450 million in Roivant equity, with additional potential regulatory and commercial milestone payments.